51. Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
- Author
-
Noriho Iida, Tatsuya Yamashita, Eishiro Mizukoshi, Kazumi Fushimi, Kuniaki Arai, Masaaki Kitahara, Shuichi Kaneko, Takeshi Terashima, and Hidetoshi Nakagawa
- Subjects
0301 basic medicine ,Male ,Cancer Research ,Pathology ,medicine.medical_treatment ,MDSC ,Kaplan-Meier Estimate ,0302 clinical medicine ,Immunophenotyping ,T-Lymphocyte Subsets ,Antineoplastic Combined Chemotherapy Protocols ,Immunology and Allergy ,Interferon gamma ,Myeloid Cells ,Cancer ,Liver Neoplasms ,Middle Aged ,Prognosis ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Cytokines ,Female ,Immunotherapy ,medicine.drug ,Sorafenib ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Regulatory T cell ,Immunology ,Immunomodulation ,03 medical and health sciences ,Antigens, Neoplasm ,medicine ,Humans ,Infusions, Intra-Arterial ,Lymphocyte Count ,Aged ,Neoplasm Staging ,HLA-A Antigens ,business.industry ,medicine.disease ,digestive system diseases ,030104 developmental biology ,Chemotherapy, Cancer, Regional Perfusion ,CTL ,Myeloid-derived Suppressor Cell ,Cancer research ,business - Abstract
金沢大学先進予防医学研究センター / 金沢大学医薬保健研究域医学系, Hepatic arterial infusion chemotherapy (HAIC) has been employed as an alternative therapy to sorafenib for the patients with advanced hepatocellular carcinoma (HCC). In this study, we performed a comparative analysis of various immune cell responses including tumor-associated antigen (TAA)-specific T cells, regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) in advanced HCC patients treated with HAIC. Thirty-six HCC patients were examined in the study. Interferon gamma enzyme-linked immunospot assays were performed to examine the frequency of TAA-specific T cells. The frequencies of Tregs and MDSCs were examined by multicolor fluorescence-activated cell sorting analysis. The treatment with HAIC using interferon (IFN)/5-fluorouracil (FU) or IFN/FU + cisplatin modulated the frequencies of various immune cells. In 22.2 % of patients, the frequency of TAA-specific T cells increased after HAIC. Although the frequency of Tregs decreased after HAIC, it was not associated with the prognosis of patients. An analysis of prognostic factors for overall survival identified diameter of the tumor (
- Published
- 2015